Company page

Ab Science Sa

Ab Science SA is a public company listed on the French market under the ticker AB, with a market capitalization of approximately €68 million. The company focuses on the development of innovative treatments for serious diseases, utilizing its expertise in biotechnology. Ab Science is committed to advancing its research and clinical trials to bring new therapies to patients.